BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• 

  Drug Development

  Sanofi Abandons Multiple Mid-Stage Drug Programs

  The company eleased the pipeline update at its Q4 earnings report.

  February 8, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Biotech Bay

  Bay Area’s Rani Therapeutics Lands $53M as Company Moves to Clinical Trials

  Rani said the latest funding round brings its coffers a total of $142M.

  February 8, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  What the Future Looks Like for Gilead and Its $36.7B Cashpile

  The company’s management has a lot on its plate in 2018.

  February 8, 2018

   · 

  1 min read
• 

  Policy

  Zimmer Biomet Dinged by the FDA Over Issues at Indiana Plant

  The FDA laid out eight observations it determined needed correction at the facility.

  February 8, 2018

   · 

  1 min read
• 

  Smith & Nephew Unveils $160M Cost-Cutting Plan

  The plan is an effort to ward off pressure to break up the firm by activist investor Elliott Advisors.

  February 8, 2018

   · 

  1 min read
• 

  Business

  Arbutus Cuts 31% of Global Workforce, to Shutter Its Burnaby Facility

  Arbutus said it was undertaking the restructuring in order to better align its hepatitis B business in Warminster, Penn.

  February 8, 2018

   · 

  2 min read

   · 

  Alex Keown